|
| |
Articles
1-100 out of 100 article(s)
| Title |
Author |
Type |
Date |
Words |
| Wall Street doesn't hold breath on inhaled insulin; MannKind stock tumbles after deal with marketing partner collapses. |
Proctor, Charles |
Company overview |
Oct 12, 2009 |
717 |
| UAS Laboratories: prizing the power of probiotics. |
|
Company overview |
Sep 1, 2009 |
826 |
| Production and Manufacturing. |
|
Directory |
Sep 1, 2009 |
1924 |
| Pharmachem Laboratories: a decade of expansion. |
|
Company overview |
Sep 1, 2009 |
723 |
| Opportunities off the beaten track in the knowledge outsourcing field: a knowledge process outsourcing sector doing well even in these challenging times is in the healthcare and pharmaceutical knowledge space. Some argue that the scale is too small to consider growth but not being overloaded has helped such companies to do well. |
Dutt, Ashish |
|
Aug 1, 2009 |
1146 |
| Amylin board headed for showdown: investors battling for control of the business. |
Chambers, Heather |
|
May 25, 2009 |
762 |
| Vacuum pumps for pharmaceutical processes: Dr Don Collins, Market Development Manager, Chemical Sector, Edwards, discusses vacuum pumping technologies and how pharmaceutical manufacturing managers can optimize their vacuum processes. |
Collins, Don |
|
May 1, 2009 |
1797 |
| New problems, new CRM solutions. |
Giardina, Annette |
|
May 1, 2009 |
1065 |
| ActiTech. |
|
Company overview |
Mar 1, 2009 |
281 |
| Alkemists Labs. |
|
Company overview |
Mar 1, 2009 |
434 |
| Blue California. |
|
Company overview |
Mar 1, 2009 |
440 |
| Gencor Nutrients, Inc. |
|
Company overview |
Mar 1, 2009 |
306 |
| Indena. |
|
Company overview |
Mar 1, 2009 |
424 |
| ProTab Laboratories. |
|
Company overview |
Mar 1, 2009 |
281 |
| Robinson Pharma Inc. |
|
Company overview |
Mar 1, 2009 |
448 |
| The way of the regulator: applying pharmaceutical principles now could pave the way to a risk-free future. |
Robinson, Kevin |
Editorial |
Mar 1, 2009 |
814 |
| IP Snapshot - January 2009. |
|
|
Feb 4, 2009 |
921 |
| Promotion Of Drugs and Devices At International Conferences Held In Canada. |
|
|
Feb 4, 2009 |
2059 |
| Winning The Battle Against Trademark Counterfeiting Through Third Party Enforcement. |
|
|
Feb 4, 2009 |
1516 |
| Modern CROS: an attractive solution for the pharmaceutical industry: Jonathan McNally, vertical marketing manager, Thermo fisher Scientific, discusses why contract research organizations (CROs) are an attractive solution in these difficult times. |
McNally, Jonathan |
|
Jan 1, 2009 |
1492 |
| New insourcing model breaks drug development mould: ever wondered where to source senior management expertise to achieve success in drug development on a completely 'as and when' basis from a single source? TranScrip Partners offers such a service, as Senior Partner, Paul Branthwaite, discusses in a Q&A with Pharma. |
Branthwaite, Paul |
Interview |
Jan 1, 2009 |
940 |
| Secrets out? Outside of the world of tv and movies, espionage doesn't feature much in our day-to-day lives. But when it comes to business, we might wonder whether event organizers are overlooking a crucial detail when planning meetings and conferences. |
|
|
Jan 1, 2009 |
811 |
| Reconnect with Mother Earth. |
|
Company overview |
Jan 1, 2009 |
454 |
| Ed Kim, MD, MBA: making the move to pharma. |
Weimar, Carrie |
|
Jan 1, 2009 |
1255 |
| The world finds relief in Littleton firm's products: Tender Corp.'s presence continues to grow steadily around the globe. |
Stone, Tracie |
Company overview |
Nov 21, 2008 |
904 |
| Predicting your health: Bloomington startup to go national. |
Mayer, Kathy |
|
Nov 1, 2008 |
367 |
| What Does The Third Amendment To China's Patent Law Mean To Pharmaceutical Companies? |
|
|
Aug 27, 2008 |
1364 |
| Hatching innovation: duo seeks to tap ex-Amgen workers for Agoura Hills startup incubator. |
Proctor, Charles |
|
Aug 25, 2008 |
1216 |
| Huya targeting China to accelerate drug production: strategy allows for less costly trials, fewer risks. |
Chambers, Heather |
|
Jul 21, 2008 |
648 |
| New drugmaker ethical code may be relevant for device companies. |
Langdon, Mark |
|
Jul 1, 2008 |
1318 |
| Adopting the CEO model--why physician executives should not be required to practice medicine. |
Lazarus, Arthur |
|
Jul 1, 2008 |
1584 |
| Drug companies drain scientific brains from FDA, leaving less confident staff. |
|
|
Jun 17, 2008 |
495 |
| Sins of omission: drug companies twist the evidence about antidepressants. |
Gaby, Alan R. |
|
May 1, 2008 |
664 |
| Collaborate for competitive success! |
|
|
May 1, 2008 |
1150 |
| Inhaled-insulin maker feels pain of rival product's flop. |
Crowe, Deborah |
Company overview |
Apr 14, 2008 |
484 |
| Pharmacy board to weigh delays on drug tracking. |
Chambers, Heather |
|
Mar 24, 2008 |
499 |
| Amerilab Technologies, Inc. |
|
Company overview |
Mar 1, 2008 |
401 |
| Cepham Inc. |
|
Company overview |
Mar 1, 2008 |
614 |
| Cognis[R] Nutrition & Health. |
|
Company overview |
Mar 1, 2008 |
407 |
| Gencor Pacific Inc. |
|
Company overview |
Mar 1, 2008 |
320 |
| Improve USA, Inc. |
|
Company overview |
Mar 1, 2008 |
227 |
| Indena. |
|
Company overview |
Mar 1, 2008 |
427 |
| Lonza. |
|
Company overview |
Mar 1, 2008 |
444 |
| Robinson Pharma Inc. |
|
Company overview |
Mar 1, 2008 |
433 |
| Ruger Chemical Co., Inc. |
|
Company overview |
Mar 1, 2008 |
537 |
| Schaefer Technologies, Inc. |
|
Company overview |
Mar 1, 2008 |
180 |
| Science inspired by nature. |
Robinson, Kevin |
Company overview |
Mar 1, 2008 |
3009 |
| Engaging the search: businesses are looking for solutions online. Are they finding you? Kelly Howard, Executive Vice President, ABI, reviews the options to increase a company's profile online. |
Howard, Kelly |
|
Mar 1, 2008 |
1661 |
| Puerto Rico's Gov. to visit drug firms Acevedo-Vila expected to ink pact with Biocom. |
Chambers, Heather |
|
Feb 18, 2008 |
813 |
| Legislation Proposed To Govern Use Of Deferred Prosecution Agreements, Selection Of Monitors, In Corporate Fraud Investigations. |
|
|
Feb 7, 2008 |
826 |
| RushNet expands. |
|
Brief article |
Feb 1, 2008 |
108 |
| We can work with pharma. |
McNeil, David |
Editorial |
Feb 1, 2008 |
649 |
| Lost in the holiday shuffle: mergers, spin-offs, settlements. |
Sanders, Bob |
|
Jan 18, 2008 |
1299 |
| Pfizer expanding incubator concept to Bay Area, Boston: pharma giant to invest millions over five years. |
Chambers, Heather |
|
Jan 14, 2008 |
839 |
| Hello from me. |
Lampard, Graham |
Brief article |
Jan 1, 2008 |
282 |
| Bank charges: a hard pill to swallow for pharma: bank charges cost the pharma industry hundreds of thousands of pounds a year and UK pharmaceutical companies are spending half a million pounds to recover missing funds, so Peter Burridge Managing Director of foreign exchange experts Travelex, says. |
Burridge, Peter |
Guest editorial |
Jan 1, 2008 |
316 |
| Exeter. |
|
Brief article |
Dec 7, 2007 |
79 |
| Participants uninformed in some halted trials. |
|
|
Nov 5, 2007 |
670 |
| Using multi-hub structures for international R&D: organisational inertia and the challenges of implementation. |
Criscuolo, Paola; Narula, Rajneesh |
|
Nov 1, 2007 |
7525 |
| Skilled Nursing Pharmacy has signed a five-year lease for 5,062 square feet of industrial space located at 9920 Scripps Lake Drive, Suite 108, in Scripps Ranch. |
Schweizer, Andrew |
Brief article |
Oct 22, 2007 |
59 |
| Mindstorm: simulating psychosis; A new virtual reality experience depicts hallucinations in 3-D. |
Tabar, Pamela |
|
Oct 1, 2007 |
1108 |
| Strategic audit: Tony Grundy explains why it's vital to give your strategy a health check. |
Grundy, Tony |
|
Sep 1, 2007 |
1382 |
| The networked industry and its pitfalls: in the following paper, Adriana Salvatore and Paolo Prisco from BearingPoint, discuss the opportunities and associated risks using a network of external professionals. The potential implications of such risks and the relevant measures that companies should put in place are detailed. |
Salvatore, Adriana; Prisco, Paolo |
|
Sep 1, 2007 |
1349 |
| Industry and psychiatry: physician, heal thyself. |
Fullerton, Catherine A. |
Viewpoint essay |
Jul 1, 2007 |
900 |
| Clinton to lower cost of AIDS drugs. |
|
Brief article |
Jun 1, 2007 |
124 |
| Cardinal becomes Catalent. |
|
Brief article |
Jun 1, 2007 |
256 |
| More with less. |
Weeks, Katie |
Brief article |
Apr 16, 2007 |
166 |
| Human infectious diseases remain focus of vicars vaccine research: biotech boasts plentiful pipeline, two drugs in late phase trials. |
Weeks, Katie |
|
Apr 2, 2007 |
897 |
| Bioenergy Life Science, Inc. |
|
Company overview |
Mar 1, 2007 |
373 |
| Indena. |
|
Company overview |
Mar 1, 2007 |
422 |
| Lomapharm. |
|
Brief article |
Mar 1, 2007 |
263 |
| Novum, LLC. |
|
Company overview |
Mar 1, 2007 |
266 |
| Robinson Pharma. |
|
Company overview |
Mar 1, 2007 |
316 |
| Stella Labs. |
|
Company overview |
Mar 1, 2007 |
424 |
| Pharma expanding post-market surveillance, says PwC report. |
|
|
Feb 26, 2007 |
315 |
| How drug companies use bully tactics to get your business. |
|
|
Feb 1, 2007 |
1086 |
| Indena: a natural at botanical production. |
|
Company overview |
Jan 1, 2007 |
658 |
| The Russian Federation: prescription for growth: the Russian pharmaceuticals market is growing very fast, and the clinical trials sector is booming. But any company that wants to do business there faces considerable challenges, as Simon Friend PricewaterhauseCoopers global pharmaceutical leader, explains. |
Friend, Simon |
|
Jan 1, 2007 |
3804 |
| Who are those guys? Using anonymized patient-level intelligence to size and characterize an undiagnosed population: anonymized patient-level intelligence can be used to provide more accurate insights into the prediabetic population. |
Carroll, Jim; Tirrell, Taryn |
|
Dec 1, 2006 |
950 |
| Gencor Pacific Inc.: a traditional approach to lifestyle management. |
|
Company overview |
Dec 1, 2006 |
755 |
| Inovio Biomedical Corp. bouncing back from shaky past, facing critical year: company raises $15.5m in sale of stock, gains $1.1m grant from U.S. Department of Defense. |
Weeks, Katie |
|
Nov 6, 2006 |
719 |
| Pharmaceutical representatives can deliver the brand promise: the sales representative plays a critical role in the marketing and branding processes. To do this, pharmaceutical reps in the field must constantly be in tune with the purpose of the companies they represent. |
Barlow, Janelle; Wardlaw, Jim |
|
Nov 1, 2006 |
2023 |
| Developing end-of-lifecycle strategies. |
Naigamwalla, Darius |
|
Nov 1, 2006 |
575 |
| Divide and conquer: novel patient-segmentation approach leads to new opportunities: anonymized patient-level data can be used to segment patients according to clinical factors, therapy usage, and demographics, allowing pharmaceutical companies to reach the right physicians and patients with the right messages. |
Carroll, Jim; Tirrell, Taryn |
|
Oct 1, 2006 |
1149 |
| Who really "Moves the Needle?" How to focus resources on the most important payer accounts. |
Lanzone, Tony |
|
Oct 1, 2006 |
1745 |
| Are You Making The Most Of The Explosion In Proprietary Device Technology? |
|
Brief article |
Sep 13, 2006 |
240 |
| Global Pharmatech, Inc. |
|
Brief article |
Sep 1, 2006 |
87 |
| The Benefits of Patents for Nutraceuticals. |
|
|
Aug 30, 2006 |
1615 |
| Cervical cancer R&D continues locally despite new vaccine: life sciences firms seek their share of $650 million market. |
Weeks, Katie |
|
Aug 7, 2006 |
990 |
| NIH scientist netted $285,000 by improperly sharing human tissue samples with Pfizer-House report. |
|
|
Jun 30, 2006 |
572 |
| SNT-MC17/idebenone--a promising drug candidate for Friedreich's Ataxia (FRDA). |
Meier, Thomas |
|
Jun 22, 2006 |
1415 |
| Companies to watch: the fab five. |
Wright, Rebecca |
Editorial |
Jun 1, 2006 |
4632 |
| Anabolic Laboratories, Inc. |
|
Company overview |
Mar 1, 2006 |
327 |
| Indena. |
|
Company overview |
Mar 1, 2006 |
462 |
| Major firms agree to disclose political gifts. |
Heffes, Ellen M. |
Brief article |
Mar 1, 2006 |
268 |
| S.D. biotech, Kansas firm part ways. |
Weeks, Katie |
|
Feb 13, 2006 |
338 |
| Biotech success could lead to CytRx payoff, but there's risk. |
Crowe, Deborah |
Company Profile |
Feb 13, 2006 |
818 |
| Campaign promotes discount drug program. |
Weeks, Katie |
|
Jan 30, 2006 |
613 |
| UCSD considers altering clinical trial procedures: change could affect how fast some drugs get on the market. |
Weeks, Katie |
|
Nov 14, 2005 |
1049 |
| Freshly washed: drug dealers, corporate swindlers cash in profits as money laundering continues to damage national image. |
Messenger, Rawdon |
|
May 1, 2004 |
1825 |
|
